The Centers for Disease Control and Prevention advisory panel has recommended the Novavax two-dose Covid-19 vaccine for emergency use authorisation.
The move makes it the fourth vaccine to clear that hurdle in the United States, and CDC Director Rochelle Walensky is expected to sign off on it later this week,
